Steven G. DuBois Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children’s Oncology Group (COG) — Parallel 8 Clinical Imaging, Risk Factors and Response
• Phase II study of alisertib, irinotecan, and temozolomide in children with relapsed and refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy (NANT) consortium — Parallel 12 Immunotherapy and Early Phase Trials